Studies have demonstrated that following the development of resistance to EGFR-TKIs, the level of tumor vascular endothelial growth factor (VEGF) increases [27], reducing tumor cell dependence on the EGFR signal and increasing dependence on the VEGF pathway. This evidence concerns the gene EGFR and neoplasm.